Positioning a Paediatric Compounded Non-Sterile Product Electronic Repository (pCNPeRx) within the Health Information Technology Infrastructure

Parrish, II Richard H.

doi:10.3390/pharmacy4010002

Cited by 4 publications

(4 citation statements)

References 15 publications

(14 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Existing federal and corporate database structures for medical language could be employed to incorporate pCNSPs to facilitate complete transmission of electronically identifiable and standardized extemporaneous formulations. The lack of inclusion also stymies a uniform approach to CMM for pediatric patients, as these products do not appear on the patients’ medication records accurately [99].…”

Section: Consistent Documentation Of Cmm By Pharmacists In Cshcn-cmentioning

confidence: 99%

Creating a Pharmacotherapy Collaborative Practice Network to Manage Medications for Children and Youth: A Population Health Perspective

et al. 2019

View full text Add to dashboard Cite

Children with special health care needs (CSHCN) use relatively high quantities of healthcare resources and have overall higher morbidity than the general pediatric population. Embedding clinical pharmacists into the Patient-Centered Medical Home (PCMH) to provide comprehensive medication management (CMM) through collaborative practice agreements (CPAs) for children, especially for CSHCN, can improve outcomes, enhance the experience of care for families, and reduce the cost of care. Potential network infrastructures for collaborative practice focused on CSHCN populations, common language and terminology for CMM, and clinical pharmacist workforce estimates are provided. Applying the results from the CMM in Primary Care grant, this paper outlines the following: (1) setting up collaborative practices for CMM between clinical pharmacists and pediatricians (primary care pediatricians and sub-specialties, such as pediatric clinical pharmacology); (2) proposing various models, organizational structures, design requirements, and shared electronic health record (EHR) needs; and (3) outlining consistent documentation of CMM by clinical pharmacists in CSHCN populations.

show abstract

Section: Consistent Documentation Of Cmm By Pharmacists In Cshcn-cmentioning

confidence: 99%

Creating a Pharmacotherapy Collaborative Practice Network to Manage Medications for Children and Youth: A Population Health Perspective

et al. 2019

View full text Add to dashboard Cite

show abstract

“…The NCPDP SCRIPT release will be a paradigm change and take us closer to more complete data transmission for CNSPs. In addition, the Pharmacy Health Information Technology Collaborative (Pharmacy HIT), formed in 2010, has developed goals related to the relationship between clinical pharmacy practice and pediatric patients, with special focus on the transmission of eRx [12]. However, variability in how CNSPs are described at the pharmacy level is a major barrier, and there is an urgent need to codify uniform vocabulary standards at the macro level.…”

Section: Introductionmentioning

confidence: 99%

Minimizing Medication Errors from Electronic Prescription Transmission—Digitizing Compounded Drug Preparations

et al. 2019

View full text Add to dashboard Cite

Lack of standardization related to compounded drug preparations, especially in the transition of care situations, threatens patient safety by facilitating medication error. This paper outlines progress to-date from the United States Pharmacopeia (USP) Expert Panel on the Exchange of Compounded Drug Preparation Information in Health IT Systems. The work plan developed for the group is focused on proposing a set of encoding rules that would govern how compounded nonsterile drug preparations (CNSPs) are digitized and exchanged, including patient electronic health records (EHR), pharmacy systems, e-prescribing (eRx), and other Health IT (HIT) systems to ensure a seamless compounding process tailored to the needs of an individual patient. Included in this work are identifying authorized compounding monographs, surveying provider and end-user groups for information about data specificity during e-prescribing, and generating guidelines for the development of a compatible data model for clinical formulation identifiers (CF-IDs). This paper will also discuss how evolving nomenclature standards for CNSPs within HIT systems are part of a quality assurance system for comprehensive medication management (CMM) in children, thereby minimizing medication errors across the continuum of care. Finally, a network approach for the design of medication management systems for children and their families/caregivers is proposed.

show abstract

“…Manufactured products approved by the United States Food and Drug Administration (USFDA) as well as those found on the British National Formulary for Children [ 5 ] are listed and coded in computerized drug databases. Conversely, pCNSPs are not listed in any electronic repository that stores and allows their transmission into patient health record through eRx processing systems [ 6 ]. In addition, compounding monographs authorized by various professional bodies are not expressed in a digital format compatible with electronic transmission.…”

mentioning

confidence: 99%

Creating Data Standards to Support the Electronic Transmission of Compounded Nonsterile Preparations (CNSPs): Perspectives of a United States Pharmacopeia Expert Panel

Parrish

Ciarkowski²,

Aguero³

et al. 2022

Children

View full text Add to dashboard Cite

The perspectives of the Compounded Drug Preparation Information Exchange Expert Panel of the United States Pharmacopeia (CDPIE-EP) on the urgent need to create and maintain data standards to support the electronic transmission of an interoperable dataset for compounded nonsterile preparations (CNSPs) for children and the elderly is presented. The CDPIE-EP encourages all stakeholders associated with the generation, transmission, and preparation of CNSPs, including standards-setting and informatics organizations, to discern the critical importance of accurate transmission of prescription to dispensing the final product and an urgent need to create and adopt a seamless, transparent, interoperable, digitally integrated prescribing and dispensing system benefiting of all patients that need CNSPs, especially for children with special healthcare needs and medical complexity (CSHCN-CMC) and for adults with swallowing difficulties. Lay summary: Current electronic prescription processing standards do not permit the complete transmission of compounded nonsterile preparations (CNSPs) from a prescriber to dispenser. This lack creates multiple opportunities for medication errors, especially at transitions of care for children with medical complexity and adults that cannot swallow tablets and capsules. The United States Pharmacopeia Expert Panel on Compounded Drug Preparation Information Exchange aims to reduce this source of error by creating ways and means for CNSPs to be transmitted within computer systems across the continuum of care. Twitter: Digitizing compounded preparation monographs and NDC-like formulation identifiers in computerized prescription systems will minimize error.

show abstract

Positioning a Paediatric Compounded Non-Sterile Product Electronic Repository (pCNPeRx) within the Health Information Technology Infrastructure

Cited by 4 publications

References 15 publications

Creating a Pharmacotherapy Collaborative Practice Network to Manage Medications for Children and Youth: A Population Health Perspective

Creating a Pharmacotherapy Collaborative Practice Network to Manage Medications for Children and Youth: A Population Health Perspective

Minimizing Medication Errors from Electronic Prescription Transmission—Digitizing Compounded Drug Preparations

Creating Data Standards to Support the Electronic Transmission of Compounded Nonsterile Preparations (CNSPs): Perspectives of a United States Pharmacopeia Expert Panel

Contact Info

Product

Resources

About